Merck

  • Zostavax 2016 report

    Zostavax 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Asmanex 2015 report

    Asmanex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Belsomra 2015 report

    Belsomra 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Cubicin 2015 report

    Cubicin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Dificid 2015 report

    Dificid 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Dulera 2015 report

    Dulera 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Emend 2015 report

    Emend 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Entereg 2015 report

    Entereg 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Follistim 2015 report

    Follistim 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this...

  • Ganirelix 2015 report

    Ganirelix 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this...

  • Gardasil 2015 report

    Gardasil 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Grastek 2015 report

    Grastek 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 28 Pages The 5 Key Questions Addressed by this...